ArticleUpdate on the management of venous thromboembolismAuthor:John R. Bartholomew, MD, FACCPublish date: December 1, 2017Once venous thromboembolism is suspected, anticoagulation should be started immediately unless there is a contraindication. In addition, other, mor...Read More
ArticleIn reply: DabigatranAuthor:John R. Bartholomew, MD, FACCPublish date: December 1, 2011Read More
ArticleDabigatran: Will it change clinical practice?Author:John R. Bartholomew, MD, FACCPublish date: October 1, 2011This new oral anticoagulant has advantages over warfarin (Coumadin), but it is more expensive, which may pose a barrier to its wider use.Read More
ArticleInterpreting The JUPITER Trial: Statins can prevent VTE, but more study is neededAuthor:John R. Bartholomew, MD, FACCPublish date: March 1, 2010The incidence of venous thromboembolism in people taking rosuvastatin (Crestor) 20 mg/day was about half that in people taking placebo. This was a ...Read More
ArticleAn algorithm for managing warfarin resistanceAuthor:John R. Bartholomew, MD, FACCPublish date: December 1, 2009Some patients need higher-than-expected doses of warfarin to reach their target INR. The cause can be acquired (poor circulation, drug interactions...Read More
